Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.77 USD | +3.04% | -3.78% | +6.26% |
05-07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
05-07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
Business Summary
Number of employees: 995
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pain Treatments
43.1
%
| 216 | 42.2 % | 221 | 43.1 % | +2.07% |
Surgical Solutions
30.1
%
| 141 | 27.6 % | 154 | 30.1 % | +9.43% |
Restorative Therapies
26.8
%
| 155 | 30.2 % | 137 | 26.8 % | -11.36% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
87.8
%
| 455 | 88.9 % | 450 | 87.8 % | -1.18% |
International
12.2
%
| 57 | 11.1 % | 62 | 12.2 % | +9.88% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Claypoole
CEO | Chief Executive Officer | 52 | 01-09 |
Mark Singleton
DFI | Director of Finance/CFO | 55 | 20/03/22 |
Katrina Church
CMP | Compliance Officer | 62 | - |
Dave Crawford
IRC | Investor Relations Contact | - | 22/08/21 |
Helen Leupold
HRO | Human Resources Officer | - | 31/05/22 |
Anthony Doyle
PRN | Corporate Officer/Principal | - | 31/03/17 |
Andrew Hosmer
PRN | Corporate Officer/Principal | - | 30/04/12 |
Anthony D'Adamio
LAW | General Counsel | 63 | 31/07/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
CHM | Chairman | 70 | 29/06/16 |
Guy Nohra
BRD | Director/Board Member | 63 | 31/12/19 |
Martin Sutter
BRD | Director/Board Member | 69 | 29/06/16 |
Susan Stalnecker
BRD | Director/Board Member | 71 | 31/08/20 |
Guido Neels
BRD | Director/Board Member | 75 | 31/12/19 |
John Bartholdson
BRD | Director/Board Member | 53 | 07/01/23 |
Mary Ladone
BRD | Director/Board Member | 57 | 14/07/21 |
Philip Cowdy
BRD | Director/Board Member | 56 | 29/06/16 |
Patrick Beyer
BRD | Director/Board Member | 58 | 28/10/21 |
Director/Board Member | 54 | 31/12/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,786,737 | 0 | 0 | 66.98 % |
Stock B | 1 | 63,827,617 | 53,329,049 ( 83.55 %) | 0 |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.26% | 357M | |
+75.69% | 12.57B | |
+12.50% | 7B | |
-30.50% | 6.78B | |
+9.11% | 5.2B | |
-19.88% | 4.67B | |
+19.81% | 4.26B | |
-21.04% | 3.84B | |
-28.39% | 2.7B | |
-1.73% | 1.98B |
- Stock Market
- Equities
- BVS Stock
- Company Bioventus Inc.